Augmented Visual Feedback for Stroke Rehabilitation
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial aims to determine if augmented visual feedback (a therapy involving enhanced visual cues) can improve arm movement in stroke survivors. Participants will use a virtual reality setup with a Leap Motion device and the Looking Glass to perform reaching exercises. The trial includes one group of healthy individuals and two groups of stroke survivors—those who experienced a stroke more than 8 months ago and those who had a stroke within the last 8 months. It suits stroke survivors who can perform certain arm movements and wish to improve their mobility. Participants will attend sessions using either enhanced visual cues or regular feedback to identify which method is more effective. As an unphased trial, this study provides a unique opportunity for stroke survivors to contribute to innovative research and potentially enhance their recovery journey.
Will I have to stop taking my current medications?
The trial protocol does not specify whether you need to stop taking your current medications. However, if you have had Botox injections in the affected arm within the past 4 months, you would not be eligible to participate.
What prior data suggests that this augmented visual feedback system is safe for stroke rehabilitation?
Research has shown that enhanced visual feedback, which improves movement visibility during therapy, is generally safe. One study found that using this feedback in balance training was both safe and more effective than traditional methods for improving balance, with participants experiencing no harmful side effects.
For accurate visual feedback that displays exact movements, studies on virtual reality therapy also suggest safety. Research indicates that virtual reality can be a helpful and safe tool in stroke recovery, improving movement without causing harm.
Both types of visual feedback have been used in various settings without major safety concerns, suggesting they are well-tolerated by users, including those recovering from a stroke.12345Why are researchers excited about this trial?
Researchers are excited about this trial because it explores innovative ways to enhance stroke rehabilitation using technology. Unlike traditional physical therapy, which primarily relies on repetitive exercises, this trial uses augmented visual feedback to encourage different movement patterns. Additionally, the trial incorporates devices like Leap Motion and the Looking Glass system to provide real-time, visual biofeedback, making therapy more interactive and engaging. By directly reflecting or augmenting arm movements, these methods aim to improve motor function more effectively and could potentially speed up recovery for stroke patients.
What evidence suggests that this trial's treatments could be effective for stroke rehabilitation?
Research has shown that enhanced visual feedback can improve balance and movement during rehabilitation. For stroke patients, visual feedback has proven effective in boosting recovery, particularly in enhancing balance and walking. This trial will compare different types of visual feedback systems. Participants in the "Chronic Augmented Visual Feedback" and "Acute Augmented Visual Feedback" arms will use augmented reality systems, which have helped individuals regain better movement in their arms and legs after a stroke. Meanwhile, participants in the "Chronic Veridical Visual Feedback" and "Acute Veridical Visual Feedback" arms will experience visual feedback that directly reflects their actual arm movements. Studies have found that virtual reality rehabilitation can significantly improve physical abilities in stroke survivors, including better arm movement and overall functional skills. Both types of visual feedback have shown promise in aiding stroke recovery.16789
Who Is on the Research Team?
James Patton
Principal Investigator
Shirley Ryan AbilityLab and University of Illinois at Chicago (UIC)
Are You a Good Fit for This Trial?
This trial is for adults who had a stroke at least 8 months ago, can move their shoulder and elbow against gravity to reach forward, but not for those with severe muscle stiffness, recent Botox in the arm, or other rehab treatments. It excludes pregnant women, children, prisoners, people with multiple strokes or severe sensory issues in the limb.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants engage in reaching interventions using the Leap motion tracker and Looking Glass system. The Chronic Arm undergoes structured sessions over 6-8 weeks, while the Acute Arm has less structured sessions during inpatient stay.
Follow-up
Participants are monitored for changes in movement ability and arm test scores after treatment. Chronic Arm follow-up occurs 2 months post-intervention.
What Are the Treatments Tested in This Trial?
Interventions
- Augmented Visual Feedback
- Bimanual Balanced Reaching With Visual Biofeedback
- Healthy Comparative Reaching Task
- Leap Motion Device
- Looking Glass
- Veridical Visual Feedback
Find a Clinic Near You
Who Is Running the Clinical Trial?
Shirley Ryan AbilityLab
Lead Sponsor